PT2633077T - Métodos analíticos e matrizes para a utilização na identificação de agentes que induzem a sensibilização na pele humana - Google Patents
Métodos analíticos e matrizes para a utilização na identificação de agentes que induzem a sensibilização na pele humanaInfo
- Publication number
- PT2633077T PT2633077T PT117916148T PT11791614T PT2633077T PT 2633077 T PT2633077 T PT 2633077T PT 117916148 T PT117916148 T PT 117916148T PT 11791614 T PT11791614 T PT 11791614T PT 2633077 T PT2633077 T PT 2633077T
- Authority
- PT
- Portugal
- Prior art keywords
- arrays
- identification
- human skin
- analytical methods
- agents inducing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/148—Screening for cosmetic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Data Mining & Analysis (AREA)
- Bioethics (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Software Systems (AREA)
- Public Health (AREA)
- Evolutionary Computation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1018014.9A GB201018014D0 (en) | 2010-10-26 | 2010-10-26 | Analytical methods and arrays for use in the same |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2633077T true PT2633077T (pt) | 2017-09-08 |
Family
ID=43365491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT117916148T PT2633077T (pt) | 2010-10-26 | 2011-10-26 | Métodos analíticos e matrizes para a utilização na identificação de agentes que induzem a sensibilização na pele humana |
Country Status (17)
Country | Link |
---|---|
US (3) | US20130274134A1 (pt) |
EP (1) | EP2633077B1 (pt) |
KR (2) | KR102115317B1 (pt) |
CN (2) | CN108624675A (pt) |
BR (1) | BR112013010272B1 (pt) |
CA (1) | CA2815892C (pt) |
CY (1) | CY1119262T1 (pt) |
DK (1) | DK2633077T3 (pt) |
ES (1) | ES2639406T3 (pt) |
GB (1) | GB201018014D0 (pt) |
HR (1) | HRP20171281T1 (pt) |
LT (1) | LT2633077T (pt) |
PL (1) | PL2633077T3 (pt) |
PT (1) | PT2633077T (pt) |
RS (1) | RS56230B1 (pt) |
SI (1) | SI2633077T1 (pt) |
WO (1) | WO2012056236A2 (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201207297D0 (en) | 2012-04-26 | 2012-06-06 | Senzagen Ab | Analytical methods and arrays for use in the same |
EP2743344A1 (en) | 2012-12-11 | 2014-06-18 | DCPrime B.V. | Therapeutic cancer vaccines derived from a novel dendritic cell line |
GB201421207D0 (en) * | 2014-11-28 | 2015-01-14 | Senzagen Ab | Analytical methods and arrays for use in the same |
GB201700138D0 (en) | 2017-01-05 | 2017-02-22 | Senzagen Ab | Analytical methods and arrays for use in the same |
CA3017270A1 (en) * | 2016-03-23 | 2017-09-28 | Senzagen Ab | Method for determining the skin sensitizing potency of an agent and arrays for use in the same |
CN107189988B (zh) * | 2017-07-17 | 2019-08-30 | 江南大学 | 一株分泌抗丁香酚单克隆抗体的杂交瘤细胞株cs12及其应用 |
GB201715445D0 (en) * | 2017-09-25 | 2017-11-08 | Senzagen Ab | Novel cell line and uses thereof |
WO2019236632A1 (en) * | 2018-06-04 | 2019-12-12 | Avon Products. Inc. | Protein biomarkers for identifying and treating aging skin and skin conditions |
US20220334130A1 (en) * | 2019-08-16 | 2022-10-20 | Research & Business Foundation Sungkyunkwan University | Melanogenesis detection method using fam86a |
KR102531515B1 (ko) * | 2019-08-16 | 2023-05-15 | 성균관대학교산학협력단 | Fam86a 억제제를 유효성분으로 포함하는 멜라닌 결핍 질환의 예방, 치료, 또는 개선용 조성물 |
KR102372647B1 (ko) * | 2019-08-16 | 2022-03-10 | 성균관대학교산학협력단 | 멜라닌 형성 검출용 조성물 및 피부 미백 물질의 스크리닝 방법 |
CN110794047A (zh) * | 2019-09-30 | 2020-02-14 | 广州市华代生物科技有限公司 | 一种复杂受试物对皮肤致敏性的预测方法 |
CN115916963A (zh) | 2020-03-27 | 2023-04-04 | 门德斯有限公司 | 白血病来源的经修饰细胞用于增强过继性细胞治疗的效力的离体用途 |
CN111879950B (zh) * | 2020-08-11 | 2021-05-25 | 苏州大学附属第二医院 | Ddrgk1作为预测胃癌患者使用铂类化疗药物预后的分子标志物的应用 |
WO2023278601A1 (en) * | 2021-06-30 | 2023-01-05 | Ampel Biosolutions, Llc | Methods and systems for machine learning analysis of inflammatory skin diseases |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE12586T1 (de) | 1980-05-02 | 1985-04-15 | Edward P Davis | Beinentlastungsgeraet. |
US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US5856090A (en) | 1994-09-09 | 1999-01-05 | The Scripps Research Institute | DNA-methylase linking reaction |
GB9703369D0 (en) | 1997-02-18 | 1997-04-09 | Lindqvist Bjorn H | Process |
EP2294412A1 (en) * | 2008-06-04 | 2011-03-16 | Ceetox Inc. | Method for predicting skin sensitizing activity of compounds |
AT507402A1 (de) * | 2008-09-16 | 2010-04-15 | Arc Austrian Res Centers Gmbh | Verfahren zur prüfung des irritierenden oder allergenen potentials eines produkts |
-
2010
- 2010-10-26 GB GBGB1018014.9A patent/GB201018014D0/en not_active Ceased
-
2011
- 2011-10-26 EP EP11791614.8A patent/EP2633077B1/en active Active
- 2011-10-26 US US13/881,576 patent/US20130274134A1/en not_active Abandoned
- 2011-10-26 PL PL11791614T patent/PL2633077T3/pl unknown
- 2011-10-26 BR BR112013010272-1A patent/BR112013010272B1/pt active IP Right Grant
- 2011-10-26 ES ES11791614.8T patent/ES2639406T3/es active Active
- 2011-10-26 CA CA2815892A patent/CA2815892C/en active Active
- 2011-10-26 SI SI201131271T patent/SI2633077T1/sl unknown
- 2011-10-26 KR KR1020197004051A patent/KR102115317B1/ko active IP Right Grant
- 2011-10-26 CN CN201810455628.9A patent/CN108624675A/zh active Pending
- 2011-10-26 CN CN201180062886.7A patent/CN103429756B/zh active Active
- 2011-10-26 WO PCT/GB2011/052082 patent/WO2012056236A2/en active Application Filing
- 2011-10-26 DK DK11791614.8T patent/DK2633077T3/en active
- 2011-10-26 RS RS20170845A patent/RS56230B1/sr unknown
- 2011-10-26 PT PT117916148T patent/PT2633077T/pt unknown
- 2011-10-26 KR KR1020137013353A patent/KR101948904B1/ko active IP Right Grant
- 2011-10-26 LT LTEP11791614.8T patent/LT2633077T/lt unknown
-
2017
- 2017-03-22 US US15/466,141 patent/US20170218449A1/en not_active Abandoned
- 2017-08-24 HR HRP20171281TT patent/HRP20171281T1/hr unknown
- 2017-08-25 CY CY20171100900T patent/CY1119262T1/el unknown
-
2021
- 2021-03-08 US US17/194,528 patent/US20210189497A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
BR112013010272A2 (pt) | 2016-09-13 |
RS56230B1 (sr) | 2017-11-30 |
CA2815892A1 (en) | 2012-05-03 |
CY1119262T1 (el) | 2018-02-14 |
KR20190016624A (ko) | 2019-02-18 |
KR101948904B1 (ko) | 2019-02-15 |
KR20140001919A (ko) | 2014-01-07 |
HRP20171281T1 (hr) | 2017-10-20 |
WO2012056236A2 (en) | 2012-05-03 |
LT2633077T (lt) | 2017-07-25 |
ES2639406T3 (es) | 2017-10-26 |
CN103429756A (zh) | 2013-12-04 |
CN103429756B (zh) | 2018-06-05 |
CN108624675A (zh) | 2018-10-09 |
GB201018014D0 (en) | 2010-12-08 |
WO2012056236A3 (en) | 2012-06-21 |
EP2633077A2 (en) | 2013-09-04 |
US20170218449A1 (en) | 2017-08-03 |
KR102115317B1 (ko) | 2020-05-26 |
CA2815892C (en) | 2021-10-19 |
SI2633077T1 (sl) | 2017-10-30 |
PL2633077T3 (pl) | 2017-11-30 |
EP2633077B1 (en) | 2017-06-07 |
US20130274134A1 (en) | 2013-10-17 |
US20210189497A1 (en) | 2021-06-24 |
DK2633077T3 (en) | 2017-08-07 |
BR112013010272B1 (pt) | 2021-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI2633077T1 (sl) | Analitski postopki in mreže za uporabo pri identifikaciji sredstev, ki inducirajo senzibilizacijo v človeški koži | |
HK1213192A1 (zh) | 用於在人類受試者中治療眼部疾病的方法和裝置 | |
HK1209100A1 (en) | N-substituted benzamides and their use in the treatment of pain n- | |
IL232256A0 (en) | Purine derivatives and their use in the treatment of diseases | |
HK1211059A1 (en) | Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method | |
EP2701621A4 (en) | METHODS AND INSTRUMENTS FOR USE IN VERTEBRAL TREATMENT | |
EP2651381A4 (en) | PROCESS FOR REDUCING TALG PRODUCTION IN THE SKIN | |
BR112012000417A2 (pt) | aparelho para uso em tratamento terapêutico e/ou cosmético | |
EP2745874A4 (en) | AUXILIARY DEVICE FOR EVALUATING A SKIN DOSE AND THERAPEUTIC PLANNING DEVICE | |
ZA201307641B (en) | Human tissue factor antibody and uses thereof | |
EP2841064A4 (en) | USE OF N-ACETYLCYSTEINE AMIDE IN THE TREATMENT OF DISEASES AND INJURIES | |
HK1187345A1 (en) | Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy | |
EP2867375A4 (en) | USE OF MARKERS IN THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER | |
EP2800975A4 (en) | ANALYSIS AND TARGETING OF ROR2 IN CANCER | |
HK1202309A1 (en) | Brown adipocyte progenitors in human skeletal muscle | |
EP2818154A4 (en) | TOPICAL PREPARATION FOR SKIN AND CELL ACTIVATION AGENT FOR HEALTHY SKIN | |
EP2896294A4 (en) | MICRORNA IN HUMAN MILK AND USE THEREOF | |
EP2636737A4 (en) | FACTOR CONTROLLING THE COLOR OF SKIN AND HAIR | |
EP2744786A4 (en) | SUBSTITUTED 2-IMIDAZOLIDINONE AND 2-IMIDAZOLONE AND THEIR USE IN THE TREATMENT OF CANCER | |
PT2670769T (pt) | R2r1/2 em diagnóstico e terapêutica | |
GB201208979D0 (en) | Skin and tissue simulant | |
HK1214771A1 (zh) | 用於治療皮膚病的製劑 | |
EP2496597A4 (en) | T CELL STIMULATING PROTEIN B AND METHOD FOR ITS USE | |
HK1209073A1 (en) | Plod-2 stimulators and their use in the treatment of skin plod-2 | |
GB201006918D0 (en) | Glycosylated agents and their use in therapy |